# Juno Therapeutics, Inc. — Form D/A

Juno Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2016-07-06. $896.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-07-06
- Form: D/A
- Accession: 0001594864-16-000002
- Industry: Biotechnology
- Exemptions: 06c
- Amount sold: $896.8M
- Investors: 2
- Date of first sale: 2015-06-29
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-243722

## Issuer

- Name: Juno Therapeutics, Inc.
- CIK: 0001594864
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 400 DEXTER AVENUE NORTH, SUITE 1200, SEATTLE, WA, 98109
- Phone: 2065821600

## Officers, directors & promoters (33)

_Showing 25 of 33 people._

| Name | Role | Location |
| --- | --- | --- |
| Marc J Tessier-Lavigne | Director | Seattle, WA |
| Hyam Levitsky | Executive Officer | Seattle, WA |
| Mark Frohlich | Executive Officer | Houston, TX |
| Mark Frohlich | Promoter | Houston, TX |
| Robert Nelsen | Director | Seattle, WA |
| Robert Nelsen | Promoter | Seattle, WA |
| Richard Klausner | Director | South San Francisco, CA |
| Richard Klausner | Promoter | South San Francisco, CA |
| Robert Azelby | Executive Officer | Redmond, WA |
| Mary Agnes Wilderotter | Director | SAN FRANCISCO, CA |
| Howard Pien | Director | Harrison, NY |
| Robert J Nelsen | Director | SEATTLE, WA |
| Robert J Nelsen | Promoter | SEATTLE, WA |
| HANS BISHOP | Director | MENLO PARK, CA |
| HANS BISHOP | Executive Officer | MENLO PARK, CA |
| HANS BISHOP | Promoter | MENLO PARK, CA |
| Anthony Evnin | Director | Cambridge, MA |
| Howard J Pien | Director | Corte Madera, CA |
| Hal J Barron | Director | Seattle, WA |
| Richard J Klausner | Director | Seattle, WA |
| Richard J Klausner | Promoter | Seattle, WA |
| Anthony J Evnin | Director | Seattle, WA |
| Sunil Agarwal | Executive Officer | Seattle, WA |
| Steven Harr | Executive Officer | Seattle, WA |
| Thomas Agnes Daniel | Director | Seattle, WA |

## Other filings by this issuer (6)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-10-05](https://search.stillhousedata.com/formd/0001594864-17-000036) | D | $31.1M | $31.1M |
| [2017-06-29](https://search.stillhousedata.com/formd/0001594864-17-000029) | D/A | — | $898.5M |
| [2015-07-14](https://search.stillhousedata.com/formd/0001594864-15-000001) | D | — | $849.8M |
| [2014-08-14](https://search.stillhousedata.com/formd/0001594864-14-000002) | D | $133.7M | $85.5M |
| [2014-05-08](https://search.stillhousedata.com/formd/0001594864-14-000001) | D | $97.0M | $28.4M |
| [2013-12-26](https://search.stillhousedata.com/formd/0001594864-13-000001) | D | $7.1M | $6.7M |

## More

- [CIK 1594864 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1594864&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001594864-16-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.